Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objectives: To report on the efficacy, safety, and tolerability of sertraline in the treatment of elderly depres‐sed patients with and without comorbid medical illness. Setting: Multicenter. Design: Randomized, double‐blind, placebo‐controlled study. Participants: A total of 752 patients aged 60 and older with diagnosis of major depressive disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition , diagnosis. Measurements: Outcome measures included the 17‐item Hamilton Depression Scale (HAMD); the Clinical Global Depression—Severity/Improvement (CGI‐S/CGI‐I); efficacy and safety/adverse event assessments; Quality of Life, Enjoyment, and Satisfaction Questionnaire; and the Medical Outcomes Study 36‐Item Short‐Form Health Status Survey. Results: In the overall sample, sertraline was superior to placebo on all three primary outcome measures, HAMD, and overall clinical severity and change (CGI‐S/CGI‐I). Furthermore, therapeutic response to sertraline was comparable in those with or without medical comorbidity, and there were no treatment‐by–comorbidity group interactions. Sertraline was also associated with a faster time to response than placebo in the comorbid group ( P <.006). Sertraline‐treated patients in the comorbid group had similar adverse events and discontinuations when compared to those in the noncomorbid group. Conclusion: Sertraline was efficacious in reducing depressive symptomatology, regardless of the presence of comorbid medical illness. Sertraline was safe and well tolerated by patients with or without medical illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465 · cited 1×
“Similarly, patients with depression and diabetes mellitus are at increased risk for poorer adherence to diet and medication regimens, greater functional impairment, and higher healthcare costs than those without depression.(10) They suffer from higher rates of a variety of diabetes mellitus complications such as diabe…”
BackgroundUnützer, J. (1997) · JAMA · doi:10.1001/jama.1997.03540440052032 · Cited by 697 · cited 1×
“Approximately 25% of patients aged 65 and older with chronic medical illness suffer fromdepressive symptomatology, with approximately 15% suffering from major depressive disorder (MDD).(1) Although specific pathophysiological mechanisms underlying such associations are poorly understood, there is a substantial body of…”
Background
Research works printed but not linked: 25
- 10.1001/jama.286.13.1621 · DOI · Paper page
- 10.1001/archpsyc.55.7.580 · DOI · Paper page
- 10.1097/00004850-199707000-00006 · DOI · Paper page
- Wassertheil‐Smoller S, 1996, Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly), Arch Intern Med, 156, 553, 10.1001/archinte.1996.00440050111012 · DOI · Paper page
- 10.1161/01.CIR.91.4.999 · DOI · Paper page
- 10.1161/hc0902.104707 · DOI · Paper page
- 10.1001/archpsyc.58.3.221 · DOI · Paper page
- De Groot M, 2001, Association of depression and diabetes complications, A meta-analysis, 63, 619
- 10.1097/00019442-200111000-00009 · DOI
- Nelson JC, 1999, Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease, Am J Psychiatry, 156, 1024, 10.1176/ajp.156.7.1024 · DOI · Paper page
- 10.1002/(SICI)1520-6394(1998)8:4<147::AID-DA3>3.0.CO;2-F · DOI · Paper page
- 10.1097/00019442-200005000-00009 · DOI · Paper page
- 10.1111/j.1532-5415.1996.tb01373.x · DOI · Paper page
- 10.1002/(SICI)1099-1166(199712)12:12<1189::AID-GPS715>3.0.CO;2-Z · DOI · Paper page
- Krishnan KR, 2001, Clinical and treatment response characteristics of late‐life depression associated with vascular disease, A pooled analysis of two multicenter trials with sertraline, 25, 347
- 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
- Guy W., 1976, ECDEU Assessment Manual for Psychopharmacology (U.S. Department of Health, Education and Welfare Publication no. (ADM) 76–338)
- Endicott J, 1993, Quality of life enjoyment and satisfaction questionnaire, A new measure, 29, 321
- 10.1093/ageing/23.3.182 · DOI · Paper page
- 10.4088/JCP.v59n0406 · DOI · Paper page
- Preskorn SH., 1998, Debate resolved, There are differential effects of serotonin selective reuptake inhibitors on cytochrome P450 enzymes, 12, S89
- 10.2165/00002512-200219040-00004 · DOI
- 10.1017/S1041610295002407 · DOI · Paper page
- Gill D, 2000, Antidepressants for depression in medical illness, Cochrane Database Syst Rev, 2, CD001312
- 10.1097/00019442-200209000-00013 · DOI
Cited by
Taylor, W. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1402180 · Cited by 394
Mitchell, A. J., & Subramaniam, H. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1588 · Cited by 348
Raskin, J., Wiltse, C. G., Siegal, A., Sheikh, J., Xu, J., Dinkel, J. J., Rotz, B. T., & Mohs, R. C. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.900 · Cited by 329
Self-citationAntidepressants for treating depression in dementia
Bains, J., Birks, J., & Dening, T. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944 · Cited by 214
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202
Metadata
- Authors
- Sheikh, J. I., Cassidy, E. L., Doraiswamy, P. M., Salomon, R. M., Hornig, M., Holland, P. J., Mandel, F. S., Clary, C. M., & Burt, T.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2003-12-24
- Volume
- 52
- Issue
- 1
- Pages
- 86-92
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W1503668654
- Cited by
- 91
- References
- 4
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness. https://app.cochat.ai/papers/10.1111/j.1532-5415.2004.52015.x
- The paper
- Sheikh, J. I., Cassidy, E. L., Doraiswamy, P. M., Salomon, R. M., Hornig, M., Holland, P. J., Mandel, F. S., Clary, C. M., & Burt, T. (2004). Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2004.52015.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.